Royal Philips (NYSE:PHG) said today it won FDA 510(k) clearance for its IntelliVue GuardianSoftware mobile client application, designed to allow clinicians to view patient vital signs and receive early warning scores on mobile devices.
The Amsterdam-based company said that the system is intended to move information that would normally be manually recorded in hospital medical-surgical units onto mobile devices to improve workflows and responsiveness, as the software can identify signs of potential patient deterioration before an adverse event.
The IntelliVue GuardianSoftware is designed for use with compatible devices such as wearable biosensors, Philips said.
“Patient deterioration continues to be a major concern in hospitals – one that can be further exacerbated when the right solutions aren’t in place. Clinicians need data in real-time to help them identify adverse events before they occur. Philips IntelliVue GuardianSoftware is always evolving to offer clinicians an intuitive tool to optimize efficiencies and clinical resources. With the introduction of the IGS mobile client app, clinicians can deploy resources more efficiently, and have a deeper view into their patients’ status,” Philips monitoring and analytics biz leader Felix Baader said in a press release.
Earlier this week, Philips saw its shares fall in New York and London after it reported lower-than-forecast sales and earnings figures.
